Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06378346 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GU-01: Glycyrrhizin in Prostate Cancer

Study acronym: GU-01
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Mar 2026 to Mar 2027 Study description revisedv9 Show 1 more changeShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  2. Primary endpoints: 2 to 1 Interventions: Glycyrrhizin (Drug), Glycyrrhizin (Other), Observation (Other) to Glycyrrhizin - 150 mg (Drug), Glycyrrhizin - 75 mg (Drug), Observation (Other) · Secondary endpoints: 26 to 3v8 Show 2 more changesShow less
    • Interventions: Glycyrrhizin (Drug), Glycyrrhizin (Other), Observation (Other) to Glycyrrhizin - 150 mg (Drug), Glycyrrhizin - 75 mg (Drug), Observation (Other)
    • Secondary endpoints: 26 to 3

    See this version in full on ClinicalTrials.gov ↗

  3. Start date changed from estimate of Jul 2024 to Jul 25, 2024v7
  4. Secondary endpoints: 17 to 26v6 See this version in full on ClinicalTrials.gov ↗
  5. Start date: Jun 2024 to Jul 2024v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: May 2024 to Jun 2024v4
  2. Trial status: Not Yet Recruiting to Recruitingv3
  3. Secondary endpoints revised (17) Study title shortened, about 6 wordsv2 Show 1 more changeShow less
    • Study title shortened, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)
Trial Details
NCT Number NCT06378346
Lead Sponsor University of Illinois at Chicago
Conditions Prostate Cancer
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov